Skip to main content
. 2015 Jun 25;107(9):djv156. doi: 10.1093/jnci/djv156

Figure 3.

Figure 3.

Survival analysis of a phase III study in treatment-naïve metastatic melanoma (4). A) Final survival analysis (n = 502). B) Iinterim milestone survival analysis (n = 300).